You are viewing an incomplete version of our website. Please click to reload the website as full version.

Ki-67 (Cell Cycle Marker) antibody

Details for Product No. ABIN93775, Supplier: Login to see New
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Clonality (Clone)
Monoclonal ()
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
Pubmed 3 references available
Supplier Login to see New
Catalog number from supplier Login to see New
Quantity 5 mL
Shipping to United States ( )
Availability Will be delivered in 4 to 5 Business Days
Immunogen Human nuclear Ki-67 antigen
Clone MIB-1
Isotype IgG1
Specificity Ki-67 nuclear protein
Research Area Proliferation Markers, Cell Cycle
Application Notes IHC(P) , Unmasking fluid G at 90-100°C neat Positive Control: Breast or colon carcinoma
Restrictions For Research Use only
Format Liquid
Buffer stabilizing phosphate buffer pH 7.3. Contains 0.09 % sodium azide. The volume is sufficient for at least 100 immunohistochemical tests (100 ul working solution / test)
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C
Background publications Gerdes, Schwab, Lemke et al.: "Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation." in: International journal of cancer. Journal international du cancer, Vol. 31, Issue 1, pp. 13-20, 1983 (PubMed).

Gerdes, Stein, Pileri et al.: "Prognostic relevance of tumour-cell growth fraction in malignant non-Hodgkin's lymphomas." in: Lancet, Vol. 2, Issue 8556, pp. 448-9, 1987 (PubMed).

Gerdes, Becker, Key et al.: "Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues." in: The Journal of pathology, Vol. 168, Issue 1, pp. 85-6, 1993 (PubMed).

Catalog No. ABIN93775
Plus shipping costs $45.00

Order hotline:

  • +1 877 302 8632
  • +1 888 205 9894 (TF)